Literature DB >> 9439724

Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.

M R Franklin1, J D Phillips, J P Kushner.   

Abstract

An experimental model of porphyria cutanea tarda, consisting of depressed hepatic uroporphyrinogen decarboxylase (URO-D) activity and accumulation of highly carboxylated porphyrins in the liver, was produced in 3 weeks in Fischer 344 rats. A single administration of a polychlorinated biphenyl mixture (Aroclor 1254) to iron-loaded female rats maintained continuously on delta-aminolevulinic acid supplemented drinking water produced the porphyric state. Without iron loading, URO-D activity appeared slightly less inhibited (33% of normal vs 23% of normal) but porphyrin accumulation was dramatically less (70 vs 605 micrograms porphyrin/g liver). Similar treatment in male rats produced URO-D activities of 54 and 70% of normal with and without iron loading, respectively, and porphyrin concentrations of 76 and 17 micrograms/g. When hexachlorobenzene was substituted for Aroclor 1254 treatment in female rats, URO-D activity was 61 and 69% of normal (with and without iron loading, respectively) and liver porphyrin concentrations were 96 and 25 micrograms/g, respectively. Hexachlorobenzene did not produce significant porphyric effects in male rats. Aroclor 1254 induced CYP1A to a greater extent in females than in males and to a greater extent than hexachlorobenzene, which showed a greater propensity to induce CYP2B. Overall correlation between URO-D activity depression and porphyrin accumulation was highest when fitted to an exponential curve, indicating the importance of the extreme of the depression URO-D activity in evoking experimental porphyria cutanea tarda.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439724     DOI: 10.1006/taap.1997.8282

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Uroporphyria in the Cyp1a2-/- mouse.

Authors:  John D Phillips; James P Kushner; Hector A Bergonia; Michael R Franklin
Journal:  Blood Cells Mol Dis       Date:  2011-08-30       Impact factor: 3.039

2.  Discovery of a gene involved in a third bacterial protoporphyrinogen oxidase activity through comparative genomic analysis and functional complementation.

Authors:  Tye O Boynton; Svetlana Gerdes; Sarah H Craven; Ellen L Neidle; John D Phillips; Harry A Dailey
Journal:  Appl Environ Microbiol       Date:  2011-06-03       Impact factor: 4.792

3.  Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda.

Authors:  Y Ma; A L Fracanzani; M Sampietro; M Mattioli; P Cheeseman; R Williams; G Mieli-Vergani; D Vergani; S Fargion
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

4.  CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.

Authors:  Jeffrey K Wickliffe; Sherif Z Abdel-Rahman; Chul Lee; Csilla Kormos-Hallberg; Gagan Sood; Catherine M Rondelli; James J Grady; Robert J Desnick; Karl E Anderson
Journal:  Mol Med       Date:  2010-10-15       Impact factor: 6.354

5.  Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications.

Authors:  Sarah A Sullivan; Bennett R Streit; Ethan L Ferguson; Paul A Jean; Debra A McNett; Louis T Llames; Jennifer L DuBois
Journal:  Anal Biochem       Date:  2015-03-10       Impact factor: 3.365

6.  Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(-/-) mice.

Authors:  Melissa L Barker; Laura B Hathaway; Dorinda D Arch; Mark L Westbroek; James P Kushner; John D Phillips; Michael R Franklin
Journal:  Chem Biol Interact       Date:  2009-09-20       Impact factor: 5.192

7.  A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.

Authors:  John D Phillips; Hector A Bergonia; Christopher A Reilly; Michael R Franklin; James P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

8.  A mouse model of familial porphyria cutanea tarda.

Authors:  J D Phillips; L K Jackson; M Bunting; M R Franklin; K R Thomas; J E Levy; N C Andrews; J P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  The Escherichia coli protein YfeX functions as a porphyrinogen oxidase, not a heme dechelatase.

Authors:  Harry A Dailey; Alecia N Septer; Lauren Daugherty; Daniel Thames; Svetlana Gerdes; Eric V Stabb; Anne K Dunn; Tamara A Dailey; John D Phillips
Journal:  MBio       Date:  2011-11-08       Impact factor: 7.867

10.  Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats.

Authors:  Janine Ezendam; Frank Staedtler; Jeroen Pennings; Rob J Vandebriel; Raymond Pieters; Johannes H Harleman; Joseph G Vos
Journal:  Environ Health Perspect       Date:  2004-05       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.